CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
RAAP - for Raw Apple in connection with re-contact with the raw apple according to an Ultra-Rush protocolother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04116580
NCT04116580N/ACompleted
CompareCT.gov

Efficacy of Oral Tolerance Induction to Raw Apple Using an Ultra Rush Protocol in 28 Rosacea Allergic Patients

Michel Bouvier·observational·Posted Oct 4, 2019·Updated Oct 8, 2019

In Brief

An observational study evaluating RAAP - for Raw Apple in connection with re-contact with the raw apple according to an Ultra-Rush protocol for Oral Allergic Syndrome and Allergic Reaction Caused by Food (Disorder). Completed, enrolled 28 participants.

Detailed Summary

The aim of the study was to describe an intensive ultra rush (UR) protocol of raw Golden apple (RGA) reintroduction in 28 in-patients, show the protocol's tolerance and the patients' follow-up at 2 months and 1 year. Patients with oral allergic syndrome (OAS) having resulted in raw fruits eviction were admitted to day hospital between June 1 2016 and October 31 2017.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOral Allergic Syndrome, Allergic Reaction Caused by Food (Disorder)
Countries--
CollaboratorsPolyclinique du Beaujolais, Clinique Charcot

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 4, 2019
Enrollment StartJun 1, 2016
Primary CompletionOct 31, 2017
Study CompletionOct 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 6.7 years ago

Interventions

RAAP - for Raw Apple in connection with re-contact with the raw apple according to an Ultra-Rush protocolother